Hematologist
CION Cancer Clinics
Venetoclax and azacitidine for unfit AML patients | CION Cancer Clinics
Venetoclax with azacitidine is a lower-intensity AML treatment for people who cannot safely have intensive chemotherapy, often older adults or those with other serious illness. It is available in India. It aims to control the leukaemia with less time in hospital, but it still lowers blood counts and needs close monitoring. This page explains who it suits, how cycles run and what to watch for. At CION Cancer Clinics, every leukaemia, MDS and MPN case is reviewed by our haematologist and discussed at a tumour board before a plan is agreed.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What is venetoclax with azacitidine, and who is it for?
- Who is this treatment usually offered to, and who not?
- What does treatment look like, cycle by cycle?
- How does it compare with intensive chemotherapy?
- What side effects should the family expect?
- What do families often misunderstand about this treatment?
- What do the words in the treatment notes mean?
- Common questions about venetoclax and azacitidine
The short answer
What is venetoclax with azacitidine, and who is it for?
Venetoclax with azacitidine is a lower-intensity treatment for AML in people who are not fit enough for intensive chemotherapy. It is used in India, often for older adults or those with other serious illnesses. It aims to control the leukaemia and give more good time, usually with less time in hospital.
How the two medicines work together
Azacitidine is given as an injection under the skin or into a vein for a few days at the start of each cycle. It changes how leukaemia cells switch their genes on and off. Venetoclax is a tablet. It blocks a protein called BCL-2 that leukaemia cells use to avoid dying. Together they work better than azacitidine alone for many people.
What "unfit" actually means
Being called unfit for intensive treatment is not a judgement on the person. It means the heart, lungs, kidneys, age or general strength make weeks of very low counts in hospital too risky. The team looks at the whole person, not just the birth year on the report.
Your haematologist sets the dose and schedule. Never change, skip or stop a tablet on your own.Is it right for us?
Who is this treatment usually offered to, and who not?
These are broad patterns. The final choice depends on test results and a conversation with your haematologist.
Often considered for
People newly diagnosed with AML who cannot safely have intensive induction.
- Older adults, especially over their mid-seventies
- Serious heart, lung, kidney or liver problems
- Poor general strength at diagnosis
Sometimes used for
Selected people whose AML has come back, or as a bridge while a transplant is being arranged, depending on the team's judgement. It may also be discussed when AML follows an earlier blood disorder or earlier cancer treatment.
Evidence in these settings is less settled than for newly diagnosed unfit patients.Usually not the first choice for
Younger, fit people who can have intensive chemotherapy and possibly a transplant. For them, intensive treatment is generally preferred.
- Acute promyelocytic leukaemia, which is treated differently
- Anyone who cannot attend frequent blood tests
Not sure whether this applies to you?
Ask an oncologistThe pathway
What does treatment look like, cycle by cycle?
-
Tests and preparation
Blood tests, a marrow test and genetic tests are done first. Many teams start the first cycle in hospital, because the leukaemia can break down quickly and upset the kidneys and blood salts.
-
The starting phase
The tablet is usually started gently and built up over the first days, with frequent blood tests. Plenty of fluids and medicines to protect the kidneys are given.
-
Injection days
Azacitidine is given for a few days in each cycle, often as day care once things are settled.
-
The rest of the cycle
Tablets continue at home as prescribed. Counts are checked often, and transfusions are given when needed.
-
Marrow check and adjustment
After the first cycle or two, a marrow test shows how the leukaemia is responding. The team may pause tablets or shorten the tablet days in later cycles to let counts recover.
-
Continuing
If it is working and tolerated, cycles usually continue for as long as they help.
Side by side
How does it compare with intensive chemotherapy?
Venetoclax with azacitidine
Intensive induction
Much of it given as day care or tablets at home
Usually several weeks in hospital
Continues in cycles for as long as it helps
A fixed number of courses
Designed for people who cannot take intensive treatment
Designed for fitter people, often leading to transplant
Low counts and infections still common
Very low counts and serious infections expected
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
What to watch for
What side effects should the family expect?
Low blood counts are the main effect. White cells, platelets and haemoglobin can all fall, especially in the first cycles. That means infections, bruising, bleeding and tiredness. Fever with low counts needs the emergency department the same day.
Tumour lysis in the first days
When many leukaemia cells die at once, they release salts that can strain the kidneys. This is called tumour lysis. It is why the first cycle is closely monitored with blood tests and fluids. Tell the team about passing less urine, cramps or an irregular heartbeat.
Other effects
Nausea, loose motions, constipation and redness at the injection site are common and usually manageable. Venetoclax interacts with several other medicines, including some antifungal medicines and antibiotics. Show every tablet the person takes, including ayurvedic and herbal products, to the haematologist.
What this page cannot tell you
It cannot tell you how well this treatment will work for your family member, or for how long. That depends on the genetic type of the leukaemia, how the marrow responds and how well the person copes with low counts. Some people respond well and others do not. Your haematologist can explain the outlook for this person after the first marrow check, and it is fair to ask plainly.
Grapefruit and some fruit juices can affect venetoclax levels. Ask the team what to avoid.Commonly believed
What do families often misunderstand about this treatment?
"Tablets mean it is a mild treatment."
Venetoclax is a tablet, but it can push counts very low and cause serious infections. Treat every fever as urgent, just as you would with intensive chemotherapy.
"Lower intensity means the doctors have given up."
This treatment is chosen because it fits the person. For many, it controls the leukaemia and allows time at home with family. It is active treatment, not only comfort care.
"If counts are low, we should skip tablets."
Only the haematologist decides whether to pause or change tablets. Stopping on your own can let the leukaemia grow back. Call the team instead.
"A cheaper tablet from anywhere will work the same."
Buy only what the treating team prescribes, from a licensed pharmacy with a proper bill. Medicines of uncertain quality can fail or cause harm. If cost is a worry, tell the team openly, because they may know of approved lower-cost options.
On your report
What do the words in the treatment notes mean?
- Ramp-up
- Starting the tablet at a low level and building up, to protect the kidneys.
- Cycle
- One round of treatment plus rest, repeated in a set pattern.
- Complete remission
- No leukaemia seen in the marrow and counts recovered. It is a good response, not proof the disease has gone for good.
- Count recovery
- White cells and platelets rising back towards safer levels.
- Unfit for intensive chemotherapy
- Too high a risk of harm from intensive treatment, judged on health, not age alone.
Questions we are asked
Common questions about venetoclax and azacitidine
Is venetoclax available in India?
Yes. Venetoclax and azacitidine are both available in India, including versions made by Indian manufacturers. Availability varies between cities and pharmacies. Buy only what your haematologist prescribes, from a licensed pharmacy. The treating team can guide you on reliable sources.
How long does this treatment continue?
Usually for as long as it keeps the leukaemia under control and the person tolerates it. Some people stay on it for a long time. Breaks or longer gaps between cycles may be planned to let counts recover. Your haematologist reviews this at regular points.
Can it be given at home?
The tablets are taken at home once things are settled. The injections need a clinic or day-care visit, and regular blood tests are needed throughout. The first cycle is often started in hospital for safety. Living close to the treating centre helps a lot.
What should we do if a fever starts at home?
Go to the nearest emergency department straight away, or call 108. Say the person has AML and is on venetoclax with azacitidine. A fever with low white cells can become serious within hours. Do not wait to see whether a fever tablet brings it down.
Can it lead to a transplant?
For most people on this treatment, a transplant is not planned, because they are not fit enough. A few people improve enough to be reassessed. If this is a question for your family, ask the haematologist directly. CION can coordinate assessment with qualified transplant centres.
Is it covered by schemes or insurance?
Coverage under Aarogyasri, PM-JAY, CGHS, ECHS, EHS and cashless insurance varies, especially for tablets taken at home. The rules change, so check your current entitlement before starting. Call the helpline with your card details and we will help you check what applies.
How will we know if it is working?
Blood counts over the first cycles give early clues, and a marrow test after a cycle or two shows the response more clearly. Needing fewer transfusions is often a good sign. Your haematologist can explain what the results mean for your family member, which this page cannot.
Can other medicines be taken alongside?
Many can, but venetoclax interacts with several common medicines. The team may change doses of other drugs to allow for this. Show them every tablet, syrup and herbal product before starting, and ask before adding anything new, even for a cold.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — Adult Acute Myeloid Leukemia Treatment (PDQ) - Patient Version
- Cancer Research UK — Treatment for acute myeloid leukaemia (AML)
- American Cancer Society — Treating Acute Myeloid Leukemia (AML)
- Leukemia & Lymphoma Society — Acute Myeloid Leukemia
- National Health Mission — National Health Mission
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
AML in Patients Over 70: Intensive or NotHow the intensive-or-not decision is madeFLT3, NPM1 and IDH in AML: Why Mutations MatterTest results that can change the treatment choiceAML Treatment Cost in IndiaIndicative costs and scheme coverageGoing Home Between AML CyclesStaying safe at home between treatment visits
Talk to us
Told intensive chemotherapy is too risky?
Tell us what has been found so far. CION's haematology team will review the reports and explain the treatment options that fit. One helpline serves every CION centre.